Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 645

1.

Glycaemic instability is an underestimated problem in Type II diabetes.

Praet SF, Manders RJ, Meex RC, Lieverse AG, Stehouwer CD, Kuipers H, Keizer HA, van Loon LJ.

Clin Sci (Lond). 2006 Aug;111(2):119-26.

PMID:
16613586
2.

Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes.

Hanefeld M, Koehler C, Hoffmann C, Wilhelm K, Kamke W, Gerstein H.

Diabet Med. 2010 Feb;27(2):175-80. doi: 10.1111/j.1464-5491.2009.02915.x.

PMID:
20546261
3.
4.

Relative and absolute contributions of postprandial and fasting plasma glucose to daytime hyperglycaemia and HbA(1c) in subjects with Type 2 diabetes.

Peter R, Dunseath G, Luzio SD, Chudleigh R, Choudhury SR, Owens DR.

Diabet Med. 2009 Oct;26(10):974-80. doi: 10.1111/j.1464-5491.2009.02809.x.

PMID:
19900228
6.

Targets and tactics: the relative importance of HbA, fasting and postprandial plasma glucose levels to glycaemic control in type 2 diabetes.

Woo V, Shestakova MV, Ørskov C, Ceriello A.

Int J Clin Pract. 2008 Dec;62(12):1935-42. doi: 10.1111/j.1742-1241.2008.01941.x. Review.

PMID:
19166440
7.

Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.

Bonora E.

Int J Clin Pract Suppl. 2002 Jul;(129):5-11. Review.

PMID:
12166607
8.

Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study.

Chappuis B, Braun M, Stettler C, Allemann S, Diem P, Lumb PJ, Wierzbicki AS, James R, Christ ER.

Diabetes Metab Res Rev. 2007 Jul;23(5):392-9.

PMID:
17211855
9.

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

Ann Intern Med. 2008 Oct 21;149(8):531-9.

PMID:
18936501
11.

[Usefulness of continuous glucose monitoring system (CGMS) in monitoring glycaemic profile in small children with diabetes type 1].

Głowińska-Olszewska B, Urban M, Peczyńska J, Florys B, Kowalewski M.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(4):237-43. Polish.

PMID:
16232362
13.
14.

Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemia.

Scherbaum WA, Schweizer A, Mari A, Nilsson PM, Lalanne G, Wang Y, Dunning BE, Foley JE.

Diabetes Obes Metab. 2008 Nov;10(11):1114-24. doi: 10.1111/j.1463-1326.2008.00875.x. Epub 2008 Mar 18.

PMID:
18355325
16.

Glipizide controlled-release tablets, with or without acarbose, improve glycaemic variability in newly diagnosed Type 2 diabetes.

Bao YQ, Zhou J, Zhou M, Cheng YJ, Lu W, Pan XP, Tang JL, Lu HJ, Jia WP.

Clin Exp Pharmacol Physiol. 2010 May;37(5-6):564-8. doi: 10.1111/j.1440-1681.2010.05361.x. Epub 2010 Jan 17.

PMID:
20082624
18.

Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.

Derosa G, D'Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SA, Montagna L, Gravina A, Ferrari I, Paniga S, Cicero AF.

J Clin Pharm Ther. 2006 Aug;31(4):375-83.

PMID:
16882108
19.

Mosapride, a 5HT-4 receptor agonist, improves insulin sensitivity and glycaemic control in patients with Type II diabetes mellitus.

Ueno N, Inui A, Asakawa A, Takao F, Komatsu Y, Kotani K, Nishimura R, Kasuga M.

Diabetologia. 2002 Jun;45(6):792-7. Epub 2002 May 15.

PMID:
12107722
20.

Excess glycaemic excursions after an oral glucose tolerance test compared with a mixed meal challenge and self-measured home glucose profiles: is the OGTT a valid predictor of postprandial hyperglycaemia and vice versa?

Meier JJ, Baller B, Menge BA, Gallwitz B, Schmidt WE, Nauck MA.

Diabetes Obes Metab. 2009 Mar;11(3):213-22. doi: 10.1111/j.1463-1326.2008.00922.x. Epub 2008 Jun 16.

PMID:
18564177

Supplemental Content

Support Center